Integrins traffic rapidly via circular dorsal ruffles and macropinocytosis during stimulated cell migration Z Gu, EH Noss, VW Hsu, MB Brenner Journal of Cell Biology 193 (1), 61-70, 2011 | 223 | 2011 |
Fibroblast‐like synoviocytes in inflammatory arthritis pathology: the emerging role of cadherin‐11 S Kyung Chang, Z Gu, MB Brenner Immunological reviews 233 (1), 256-266, 2010 | 189 | 2010 |
Dystrophin is a tumor suppressor in human cancers with myogenic programs Y Wang, A Marino-Enriquez, RR Bennett, M Zhu, Y Shen, G Eilers, JC Lee, ... Nature genetics 46 (6), 601-606, 2014 | 179 | 2014 |
Confinement sensing and signal optimization via Piezo1/PKA and myosin II pathways WC Hung, JR Yang, CL Yankaskas, BS Wong, PH Wu, C Pardo-Pastor, ... Cell reports 15 (7), 1430-1441, 2016 | 175 | 2016 |
Cadherin-11 regulates fibroblast inflammation SK Chang, EH Noss, M Chen, Z Gu, K Townsend, R Grenha, L Leon, ... Proceedings of the National Academy of Sciences 108 (20), 8402-8407, 2011 | 175 | 2011 |
Soft matrix is a natural stimulator for cellular invasiveness Z Gu, F Liu, EA Tonkova, SY Lee, DJ Tschumperlin, MB Brenner Molecular biology of the cell 25 (4), 457-469, 2014 | 71 | 2014 |
Aquaporin 2 promotes cell migration and epithelial morphogenesis Y Chen, W Rice, Z Gu, J Li, J Huang, MB Brenner, A Van Hoek, J Xiong, ... Journal of the American Society of Nephrology 23 (9), 1506-1517, 2012 | 71 | 2012 |
Caldesmon phosphorylation in actin cytoskeletal remodeling CM Hai, Z Gu European journal of cell biology 85 (3-4), 305-309, 2006 | 66 | 2006 |
Erk1/2 MAPK and caldesmon differentially regulate podosome dynamics in A7r5 vascular smooth muscle cells Z Gu, J Kordowska, GL Williams, CLA Wang, CM Hai Experimental cell research 313 (5), 849-866, 2007 | 65 | 2007 |
Bioengineering paradigms for cell migration in confined microenvironments KM Stroka, Z Gu, SX Sun, K Konstantopoulos Current opinion in cell biology 30, 41-50, 2014 | 55 | 2014 |
Nicotinic acetylcholine receptor mediates nicotine-induced actin cytoskeletal remodeling and extracellular matrix degradation by vascular smooth muscle cells Z Gu, V Fonseca, CM Hai Vascular pharmacology 58 (1-2), 87-97, 2013 | 35 | 2013 |
E3 ligase MKRN3 is a tumor suppressor regulating PABPC1 ubiquitination in non–small cell lung cancer K Li, X Zheng, H Tang, YS Zang, C Zeng, X Liu, Y Shen, Y Pang, S Wang, ... Journal of Experimental Medicine 218 (8), e20210151, 2021 | 30 | 2021 |
An electro-osmotic microfluidic system to characterize cancer cell migration under confinement TH Hui, WC Cho, HW Fong, M Yu, KW Kwan, KC Ngan, KH Wong, Y Tan, ... Journal of the Royal Society Interface 16 (155), 2019 | 17 | 2019 |
Cytokinesis machinery promotes cell dissociation from collectively migrating strands in confinement RA Law, A Kiepas, HE Desta, E Perez Ipiņa, M Parlani, SJ Lee, ... Science Advances 9 (2), eabq6480, 2023 | 12 | 2023 |
CRISPR/Cas9 edited RAS & MEK Mutant cells acquire BRAF and MEK inhibitor resistance with MEK1 Q56P restoring sensitivity to MEK/BRAF inhibitor combo and KRAS G13D gaining … E Turner, L Chen, JG Foulke, Z Gu, F Tian Cancers 14 (21), 5449, 2022 | 6 | 2022 |
Post-EMT: Cadherin-11 mediates cancer hijacking fibroblasts eLife 12, RP87423, 2023 | 2* | 2023 |
0.1 kilopascal difference for mechanophenotyping: soft matrix precisely regulates cellular architecture for invasion Z Gu Bioarchitecture 4 (3), 116-118, 2014 | 2 | 2014 |
Discovery of predictive biomarkers of response to T cell-targeting biologics using ex vivo single-cell profiling coupled with TCR clonotype characterization D Lee, M Manne, R Kumar, R Silver, A Staskus, J Crivello, Z Wang, D Lee, ... Cancer Research 82 (12_Supplement), 618-618, 2022 | 1 | 2022 |
Optimizing ex vivo CAR-T cell-mediated cytotoxicity assay through multimodality imaging JG Foulke, L Chen, H Chang, CE McManus, F Tian, Z Gu Cancers 16 (14), 2497, 2024 | | 2024 |
Luciferase reporter cell lines allow simultaneous incorporation of tumor cells, innate immune cells, and adaptive immune cells for in-depth immune checkpoint studies H Chang, AC Walker, JG Foulke, L Chen, F Tian, Z Gu Cancer Research 84 (6_Supplement), 75-75, 2024 | | 2024 |